ðŸð± ç¬ç«ãã¥ãŒã¹ â 2026.11.15
ç¬4 ïŒ ç«2 ïŒ èš6ä»¶
ðŸ ç¬ãã¥ãŒã¹ â 2026.11.15
æ¬æ¥ 4ä»¶
ð¥ å»çã»çŸç ã»äºé²
ç¬ãã«ããŠã€ã«ã¹ææçã13幎ã§å¹Žéçºççã1äžé ããã45.2ä»¶ãã6.5ä»¶ãžçŽ85%æžå°ââããã§ãçµæãåãã£ãç¬ã®43.6%ã14æ¥ä»¥å ã«æ»äº¡ãçŽ46%ã¯çåŸ8ã16é±ã®åç¬(Banfieldåç©ç é¢ã®çŽ7äž9,000é ãJAVMA)
ð 2026.09.08
ç±³åœã®åç©ç é¢ãã§ãŒã³Banfield Pet Hospital(43å·ã»ã¯ã·ã³ãã³DCã»ããšã«ããªã³ã®1,000以äžã®äžæ¬¡èšºçç é¢)ã®é»åã«ã«ãã䜿ããç¬ãã«ããŠã€ã«ã¹ææçã®çºçãšäºåŸã®å€åã調ã¹ãç ç©¶ããç±³åœç£å»åž«äŒéèª(JAVMA)ã«2026幎8æ31æ¥ä»ã§ãªã³ã©ã€ã³æ²èŒãããŸãããçé èè ã¯JoAnn Morrisonæ°ã§ã2010幎1æ1æ¥ãã2023幎6æ30æ¥ãŸã§ã«åããŠãã«ããŠã€ã«ã¹ææçãšèšºæãããç¬7äž8,977é ãåŸãåãã«è§£æããŠããŸãã幎éã®çºççã¯2010幎ã®1äžé ããã45.2ä»¶ãã2022幎ã«ã¯6.5ä»¶ãžãšçŽ85.6%æžå°ãã14æ¥ä»¥å ã®æ»äº¡ã»å®æ¥œæ»ã®å²åã2010ã2012幎ã¯45%è¶ ã§ãããã2018ã2023幎ã¯40%æªæºã«äžãããŸãããäžæ¹ã§ã2022幎ã ãã§ã2,000é 以äžã蚺æãããŠããã14æ¥åŸã®è»¢åž°ãåãã£ã3äž7,707é ã®ãã¡43.6%ã¯14æ¥ä»¥å ã«æ»äº¡ãŸãã¯å®æ¥œæ»ããŠããŸãããçäŸã®çŽ46%ã¯çåŸ8ã16é±ã®åç¬ã§ã蚺ææã®å¹Žéœ¢ã®äžå€®å€ã¯2010幎ã®17é±ãã2022幎ã¯14é±ã«äžããã蚺æã¯4ã6æã«å€ãå¬ã«å°ãªãåŸåã§ããã80%以äžãé¿åŠã»å»å¢ãããŠããªãç¬ã§ãã¯ã¯ãã³æ¥çš®æŽã¯90%以äžã§èšé²ããªãã蚺ææã®äœã¿ã³ãã¯è¡çãäœäœéããªã³ãçãçœè¡çã®æžå°ãèé µçŽ ã®äžæã¯æ»äº¡ãªã¹ã¯ã®é«ããšé¢é£ããŠããŸããã
ç ç©¶ããŒã ã¯ãçºçã¯å€§ããæžã£ããã®ã®ããã«ããŠã€ã«ã¹ã¯ä»ããç±³åœå šäœã®ç¬ã«ãšã£ãŠå€§ããªãªã¹ã¯ãã§ããç¶ããŠãããšåŒ·èª¿ããŠããŸããã¯ã¯ãã³èšé²ãäžå®å šãªããšãçåã®å€æãç é¢ãžã®åæ¥é¢ã«é Œã£ãŠããããšãç é¢ã®ååžãå°ççã«åã£ãŠããããšãªã©ãéçãšããŠæããããŠãããæ¥æ¬ã®ç¶æ³ã«ãã®ãŸãŸåœãŠã¯ãŸãããã§ã¯ãããŸãããããã§ããã¯ã¯ãã³ãå®äºããåã®åç¬ã®ææã«çºçãéäžããŠããããšã¯ãæ¥æ¬ã®é£Œãäž»ã«ãå ±éããæ³šæç¹ã§ããåç¬ãè¿ããããç£å»åž«ãšçžè«ããŠæ±ºããã¹ã±ãžã¥ãŒã«ã©ããã«ã¯ã¯ãã³ãæåŸãŸã§æ¥çš®ããæ¥çš®ãçµãããŸã§ã¯äžç¹å®å€æ°ã®ç¬ãéãŸãå Žæãé¿ããŸããããååãäžç¢ãå æ°ã飿¬²ã®äœäžãèŠãããããæ§åãèŠãã«ããã«åç©ç é¢ãå蚺ããŠãã ããã
ð·ïž å»çã»çŸç ã»äºé²
ð¥ å»çã»çŸç ã»äºé²
ç±³åœåç©ç é¢åäŒ(AAHA)ãç¬ã®ç³å°¿ç ã®ç®¡çã¬ã€ãã©ã€ã³ã2018å¹Žä»¥æ¥æ¹èšââãç³å°¿ç ã®ç¬ã¯ãã¹ãŠã€ã³ã¹ãªã³ãå¿ èŠããé£äºã®ã¿ã€ãã³ã°ã«åãããªããŠããæç¶åã€ã³ã¹ãªã³ãé£ç¶è¡ç³æž¬å®åšã®æŽ»çšãçã蟌ã(JAAHAãAVMA News)
ð 2026.09.24
ç±³åœåç©ç é¢åäŒ(AAHA)ã¯ã2026 AAHAç¬ã®ç³å°¿ç 管çã¬ã€ãã©ã€ã³ããJournal of the American Animal Hospital Associationèª(62å·»5å·)ã«çºè¡šããŸãããAVMA Newsã«ãããšã2018幎çã®ã¬ã€ãã©ã€ã³ãåå°ã«ç¬ã«ç¹åããŠæ¹èšãããã®ã§ãç«åãã®çã¯2026å¹Žã®æ©ãææã«ãã§ã«å ¬è¡šãããŠããŸããã¬ã€ãã©ã€ã³ã¯ãç¬ã®ç³å°¿ç ã¯èµèã®Î²çްèãæ°žä¹ ã«å€±ãããããšã«ããã絶察çãªã€ã³ã¹ãªã³äžè¶³ãã§ãããç«ãšã¯ç°ãªããšããŠããç³å°¿ç ã®ç¬ã¯ãã¹ãŠã€ã³ã¹ãªã³ãäžè¶³ããŠãããã€ã³ã¹ãªã³æ²»çãå¿ èŠããšæèšããŠããŸããæ³šç®ç¹ãšããŠãã€ã³ã¹ãªã³ã»ãã°ã«ãã¯ãã€ã³ã¹ãªã³ã»ã°ã©ã«ã®ã³U-300ã®ãããªå¹ãç®ã®ããŒã¯ããªãæç¶å(åºç€)ã€ã³ã¹ãªã³ã¯ãå¹ãæ¹ãå¹³åŠã§æ¥ã ã®è¡ç³ã®å€åãå°ãªããé£äºã®ã¿ã€ãã³ã°ã«åãããå¿ èŠããªããé£äºãæãããšãã«ãäœè¡ç³ãèµ·ããã«ãããšç޹ä»ããŠããŸããäœæã¡ã³ããŒã®Audrey K. Cookæ°ã¯ãå®äŸ¡ãªé£ç¶è¡ç³æž¬å®åšã®ç»å Žãšæç¶åã€ã³ã¹ãªã³ã®æŽ»çšã§ãç³å°¿ç ã®ç¬ã®ã±ã¢ã¯ãããæ°å¹Žã§åçã«å€ãã£ãããšè¿°ã¹ãŠããŸãããŸããäœè¡ç³ãèŠã€ããããã®ã¯è¡ç³å€(ãŸãã¯ç®äžã®é質液ã®ã°ã«ã³ãŒã¹å€)ã®æž¬å®ã ãã§ããããšãã€ã³ã¹ãªã³ã®éã¯æšå®ãããçæ³äœéããèšç®ããŠ1åäœæªæºã¯åãæšãŠãããšãªã©ã瀺ãããŠããŸãã
飿¬²ã«ãããããç¬ããã¯ãã·ã³ã°çå矀(å¯è ç®è³ªæ©èœäº¢é²ç)ãªã©ã»ãã®ç æ°ãæã€ç¬ã§ã䜿ããããæ²»çã®éžæè¢ãæŽçãããããšã¯ã飌ãäž»ã«ãšã£ãŠãå¿åŒ·ãå 容ã§ããã¬ã€ãã©ã€ã³ã¯ãæ²»çã®ç¬¬äžã®ç®æšã¯å€é£²å€å°¿ãªã©ã®çç¶ãæããããšã§ãããé©åãªæ²»çãšèгå¯ãç¶ããã°äºåŸã¯è¯å¥œã ãšããŠããŸããäžæ¹ã§ããã£ãããããç ããã«ããŠããããã€ããšéãè¡åããµãã€ããè±åããããããšãã£ãäœè¡ç³ã®ãµã€ã³ã飌ãäž»ãç¥ã£ãŠããããã®ãšãã®å¯ŸåŠæ³ãæžé¢ã§åãåã£ãŠããããšãæ±ããŠããŸãããªããããã§æããããã€ã³ã¹ãªã³è£œå€ãæ¥æ¬ã§ç¬ã«äœ¿ãããã©ããã¯åå¥ã«ç°ãªããŸããæ°Žããããã飲ããããã£ãã®éãå¢ãããé£ã¹ãŠããã®ã«ãããŠãããªã©ã®å€åãããã°æ©ãã«å蚺ããæ²»çäžã®ç¬ã¯è¡ç³ã®æž¬ãæ¹ãäœè¡ç³æã®å¯Ÿå¿ã«ã€ããŠããããã€ãã®ç£å»åž«ãšããçžè«ããŠãã ããã
ð https://www.avma.org/news/aaha-releases-canine-focused-diabetes-guidelines
ð·ïž å»çã»çŸç ã»äºé²
𥩠æ é€ã»é£äºã»ãµããª
ãããçšãµããªã61%ã®ååããŒãžã§æåããšã®éãèšèŒããã99%ã¯è£œåãã®ãã®ã®èšåºè©Šéšãªãââ56ãã©ã³ãã®èª¿æ»ããç£å»åž«ãé åããšæžããŠè£ä»ãã®ãªããã©ã³ãã21(AVMA News)
ð 2026.10.21
ç±³åœç£å»åž«äŒ(AVMA)ã®ãã¥ãŒã¹ãµã€ãAVMA Newsã¯ããããçšãµããªã¡ã³ãã®æ å ±éç€ºãšæ³çãªäœçœ®ã¥ããæŽçããèšäºãæ²èŒããŸãããèšäºã«ãããšãDog Aging Projectã®ããŒã¿ã䜿ã£ã2025幎ã®ç ç©¶ã§ã¯ãç¬ã®52%ã幎霢ãéããã«ã€ããŠãµããªã¡ã³ãã®ãããªè£œåãäžããããŠãããå€ãã®ã¯ãªã¡ã¬3èèªé žãå«ããã®ãšé¢ç¯ã®å¥åº·ãããããã®ã§ãããèšäºã玹ä»ããã®ã¯ããããçšãµããªã¡ãŒã«ãŒã®La Petite Labsãè¡ã£ãæ¥ç調æ»ã§ãèªç€Ÿè£œåãé€ã145ã®ååã«ããŽãªãŒãš56ãã©ã³ãã調ã¹ããã®ã§ãããã®çµæãååããŒãžã®61%ã¯æå¹æåããšã®éãæ°åã§ç€ºããŠãããã56ãã©ã³ãäž21ãã©ã³ãã¯æ ¹æ ã瀺ããã«ãç£å»åž«ãé åããšãããã38%ã®ãã©ã³ãã§ã¯ç£å»åž«ãç§åŠè ãªã©é åã®è²¬ä»»è ãç¹å®ã§ããŸããã§ãããããã«ã99%ã®ååããŒãžã«ã¯æçµè£œåãã®ãã®ã®èšåºè©Šéšãå ¬è¡šãããŠãããã92%ã¯æååæèšŒææž(COA)ãäžè¬ã«å ¬éããŠããŸããã§ãããç±³åœé£åå»è¬åå±(FDA)ã¯ããããçšãµããªã衚瀺ãçšéã«ãã£ãŠãé£åãããå»è¬åãã«åé¡ããŠãããç æ°ã®æ²»çãäºé²ãããã補åã¯å»è¬åãšããŠã®èŠä»¶ãæºããå¿ èŠããããŸãã
AVMA Newsã¯ããã®èª¿æ»ããµããªã¡ãŒã«ãŒèªèº«ã«ãããã®ã§ç¬ç«ãã調æ»ã§ã¯ãªãç¹ãæèšããŠããŸãããŸããçŸè¡ã®ã«ãŒã«ã§ã¯ããã以äžã®æ å ±éç€ºã¯æ³åŸäžæ±ããããŠããªããšãã€ã€ãæåã®éææ§ãé«ããã°ãç£å»åž«ã補åãè©äŸ¡ãããã誀ã£ãŠå€§éã«é£ã¹ãŠããŸã£ããšãã«å¯Ÿå¿ããããããããªããšææããŠããŸãã補åãéžã¶ç®å®ãšããŠãæ²»çãäºé²ã§ã¯ãªããå¥åº·ã®ãµããŒãããããã£ãŠããããšãæåãš1åãããã®éãã¯ã£ããæžãããŠããããšããããçªå·ãããããšãåè³ªãæ€æ»ã«ã€ããŠçããŠãããåãåããå ãããããšãæããããŠããŸããç±³åœã®æ¥çå£äœNASCã®å質ã·ãŒã«ã倿ææã®ã²ãšã€ã§ããæ¥æ¬ã§ãé¢ç¯ãã·ãã¢åãã®ãµããªã¯å€ã販売ãããŠããŸãããè¬ãšã®é£²ã¿åãããæç ãžã®åœ±é¿ããããããæ°ããäžããåãããã§ã«äžããŠãããã®ãç¶ãããè¿·ã£ããšãã¯ã補åã®ããã±ãŒãžãæã£ãŠãããã€ãã®ç£å»åž«ã«çžè«ããŸãããã
ð https://www.avma.org/news/pet-supplement-companies-dont-disclose-full-details-legally-do-they-need
ð·ïž æ é€ã»é£äºã»ãµããª
𧬠ç ç©¶ã»ç§åŠ
ç¬ã®èªç¥çãã1åã®æ³šå°ãã§ââè³ã®çްèã«ä¿è·ã¿ã³ãã¯è³ªãäœãããéºäŒåæ²»çã2019幎ããéçºãç¬ã§ã®ç ç©¶ã«åããŠè³ééãã®æ®µé(åãããªã倧åŠ)
ð 2026.10.07
ç±³åœã®åãããªã倧åŠ(USF)ãã«ã¹ã»ã¢ãŒãµãå»åŠéšã®ç ç©¶å¡Aurelie Jolyæ°ãã¯ãé«éœ¢ã®ç¬ã«èŠãããèªç¥æ©èœã®äœäž(ç¬ã®èªç¥ç)ã«å¯ŸããéºäŒåæ²»çã®éçºãé²ããŠãããšçºè¡šããŸããããã®æ²»çã¯ãç æ°ãèµ·ãããªãããã«æ¹å€ãããŠã€ã«ã¹ããéã³åœ¹ãã«ããŠè³ã®çްèã«éºäŒæ å ±ãå±ãã1åã®æäžã§ãé žåã¹ãã¬ã¹ãæžããè³ã®çްèãå·å®³ããå®ãã¿ã³ãã¯è³ªã现èèªèº«ã«äœãç¶ãããããšãããã®ã§ããJolyæ°ã¯ã1åã®æ²»çã®ããšãäœã®äžã®å°ããªå·¥å Žãæçãªã¿ã³ãã¯è³ªãäœãç¶ãããããªãã®ããšèª¬æããŠããŸããå°å ãã¬ãå±FOX13ã®å ±éã«ãããšãç ç©¶ã¯2019幎ããç¶ããããŠãããç£å»åž«ã1åæ³šå°ããã ãã®æ²»çãæ³å®ããŠããŸãããããŸã§ã®ã»ãã®åç©ã§ã®ç ç©¶ã§ã¯ææãªçµæãåºãŠãããšãããŠããŸãããå ·äœçãªããŒã¿ã¯å ¬è¡šãããŠããŸãããç ç©¶ã¯ç±³åœç«ç§åŠè²¡å£(NSF)ãªã©ã®è³éãäžéšåããŠãããJolyæ°ãå倧åŠã®Kevin Nashæ°ããå ±åã§èšç«ããäŒæ¥Blue Zone Therapeuticsãéçºãé²ããŠããŸãã
Jolyæ°ã¯ãç¬ã¯å¹Žããšããšèªç¶ã«èªç¥çã®ãããªç¶æ ã«ãªãããã人ã®ã¢ã«ããã€ããŒç ã®ããããã¢ãã«ã«ãªããšè¿°ã¹ãŠãããå°æ¥ã¯ç«ã人ãžã®å¿çšãç®æããŠããŸãããã ãçŸæç¹ã§ã¯ãç¬ã§ã®èšåºè©Šéšã®é æ°ãéå§ææãå¹æã®æž¬ãæ¹ã¯ç€ºãããŠããããç¬ã§å®éã«äœ¿ããããã«ãªããŸã§ã«ã¯ããã倧éã®æ²»çè¬ã®è£œé ããç¬ã§ã®å¹æãè©äŸ¡ããæ°ããªæ¹æ³ã®éçºãå¿ èŠã ãšãããŠããŸããããŸããæ²»çã¯ãäžå®ãè¡åã®å€åãšãã£ãçç¶ãåãããããšãäžå¿ã§ããå€äžã«æ©ãåããå£ãèŠã€ããã飌ãäž»ãžã®åå¿ãå€ããããã€ã¬ã®å€±æãå¢ãããšãã£ãå€åã¯ã幎ã®ãããšããããããæ©ãã«ãããã€ãã®ç£å»åž«ã«çžè«ããŸããããã»ãã®ç æ°ãé ããŠããªããã確èªããããã§ãç°å¢ã®å·¥å€«ãé£äºãè¬ãªã©ã§ç掻ã®è³ªãä¿ãŠãå ŽåããããŸãã
ð¡ 仿¥ã®ã¯ã³ãã€ã³ã
ã·ãã¢æã®ç¬ã¯ãã²ãšã€ã²ãšã€ã¯å°ããªå€åã§ãç©ã¿éãªããšæ®ããã«åœ±é¿ããŸããæ°Žã飲ãéã飿¬²ãäœéãæ©ãæ¹ãå€ã®éããæ¹ãªã©ãæã«äžåºŠã¡ã¢ããŠãããšãç³å°¿ç ãèªç¥æ©èœã®äœäžãšãã£ãç æ°ã®ãµã€ã³ã«æ©ãæ°ã¥ããŸãããµããªãæ°ããããŒããå§ãããšããããã®ã¡ã¢ãæã£ãŠç£å»åž«ã«çžè«ãããšãæç¬ã«åã£ãéžæããããããªããŸãã
ð± ç«ãã¥ãŒã¹ â 2026.11.15
æ¬æ¥ 2ä»¶
𧬠ç ç©¶ã»ç§åŠ
äžå¹Žæãã7幎远跡ããç«209é ã96%ãå 霢ã«äŒŽãç°åžžãçºçã84%ãè€æ°ã®ç æ°ã䜵çºââæ¯ã®ç æ°84%ãæŽåœ¢å€ç§çãªç°åžž82%ãå¿éé³59%ãäžå¹Žæã®ã軜ãçèã®è¡°ããã§æ»äº¡ãªã¹ã¯çŽ2å(è±ãªãããŒã«å€§åŠãCatPAWSããFrontiers in Veterinary Science)
ð 2026.09.24
è±ãªãããŒã«å€§åŠã¯9æ24æ¥ãç«ã®èåãé·æé远跡ããç ç©¶ãCatPAWS(Cat Prospective Ageing and Welfare Study)ããéå§ãã9幎ãè¿ããææ°ã®è§£æçµæãšãæ°ãã«æ é€ã«ããä»å ¥ã®èšåºè©Šéšãå§ããããšãçºè¡šããŸãããCatPAWSã¯ãã€ã€ã«ã«ãã³ãæ¯æŽããå倧åŠã®ãç«ã®å¥åº·é·å¯¿ã¯ãªããã¯ãã®äžç°ã§ã2017幎2æã«æåã®ç«ãç»é²ãããŠä»¥æ¥ãåèš243é ãåå ããŠããŸããFrontiers in Veterinary Scienceèªã«æ²èŒãããè«æ(Christine R. Pyeæ°ã)ã§ã¯ãäž»ã«7ã10æ³(ç»é²æã®å¹Žéœ¢ã®äžå€®å€8.1æ³)ã®äžå¹Žæã«ç»é²ãã飌ãç«209é ãã6ãæããšã«æé·7幎éãåèš1,241å蚺å¯ããããŒã¿ãè§£æããŸããããã®çµæã96%ã®ç«ã«å°ãªããšã1ã€ã®å 霢ã«äŒŽãç°åžžãèŠã€ããã84%(175é )ã¯2ã€ä»¥äžã®ç æ°ã䜵ãæã€ãå€çŸæ£äœµåãã®ç¶æ ãšãªããŸãããæãå€ãã£ãã®ã¯æ¯ã®ç æ°(84%)ãæŽåœ¢å€ç§çãªèšºå¯ã§ã®ç°åžž(82%)ãå¿éé³(59%)ã§ã远跡äžã«209é äž59é (28%)ã亡ããªãã寿åœã®äžå€®å€ã¯15.2æ³ã§ãããæ»äº¡ãªã¹ã¯ã«é¢ããèŠå ãšããŠã¯ãç»é²æã«è»œãçèã®è¡°ãããã£ãç«ã¯çèã®ç¶æ ãæ£åžžãªç«ã®çŽ2.0å(ãã¶ãŒãæ¯2.01)ãçŽè¡çš®ã®ç«ã¯éçš®ã®ç«ã®çŽ2.6å(ãã¶ãŒãæ¯2.62)æ»äº¡ãªã¹ã¯ãé«ãããšã瀺ãããŸããã
ç ç©¶ããŒã ã¯ãå¥åº·ã«å¹Žãéããããã®åãçµã¿ã¯ãæãããªç æ°ãåºãåã®äžå¹Žæããå§ããã¹ãã ãšããŠããŸããä»åŸã¯ãæ é€ã«ããä»å ¥ãèåãå¥åº·å¯¿åœã«ã©ã圱é¿ãããã調ã¹ã12ãæéã®ã©ã³ãã 忝èŒè©Šéšãè¡ãäºå®ã§ãããã ããçŽè¡çš®ã®ç«ã¯29é (14%)ãšå°ãªãã远跡ã§ããªããªã£ãç«ã28%ããããšãå¿éé³ã«ã€ããŠå¿ãšã³ãŒæ€æ»ã§å¿èã®ç æ°ãã©ããã確èªããŠããªãããšãªã©ãè«æã«ã¯éçãèšãããŠããŸããç«ã¯7æ³ããããäžå¹Žæã«å ¥ããšããããæ¯ã®çã¿ãé¢ç¯ã®äžèª¿ã¯èŠãç®ã§ã¯æ°ã¥ãã«ãããã®ã§ããèäžãè °ãŸããã®çèãèœã¡ãŠãããé«ããšããã«äžããªããªã£ããªã©ã®å€åãããã°ã幎1ã2åã®å¥åº·èšºæã®æ©äŒãå«ããŠããããã€ãã®ç£å»åž«ã«çžè«ããŸãããã
ðïž ãã¬ãŒãã³ã°ã»è¡åç§åŠ
å±ããªãããã€ãåã«ãç«ã¯ã人ããããšããã«ã ããã鳎ãââç«38é ã®å®éšã§é³Žã声ã¯äººããããš86åãã²ãšãã®ãšãã¯20åã鳎ã確çã¯16å以äžã«(ãã©ãžã«ã»ãµã³ããŠã倧åŠãAnimal Behaviour)
ð 2026.11.12
ãã©ãžã«ã»ãµã³ããŠã倧åŠã®Naila Fukimotoæ°ãã®ç ç©¶ããŒã ã¯ãç«ã人ã«å©ããæ±ããããã«æå³çã«é³ŽããŠããå¯èœæ§ã瀺ãå®éšçµæãã11æ5æ¥ã«Animal Behaviourèªã®ãªã³ã©ã€ã³çã§çºè¡šããŸãããThePrintã11æ12æ¥ã«è©³ãã玹ä»ããŠããŸããå®éšã«åå ããã®ã¯ã飌ãäž»ããé£ã¹ç©ã絡ããšãã鳎ãããšçãã飌ãç«38é ã§ããç ç©¶ããŒã ã¯ãç«ã®å¥œããªããã€ãå°ããªãã©ã¹ããã¯å®¹åšã«å ¥ãã穎ããèŠããã«ãããå ãã ãã¯ã§ãããã®ã®ãåãåºããªãç¶æ ã«ããŸããããã®ããã§ã泚æãåããŠããã人ããã°ã«ããæ¡ä»¶ãšãéšå±ã«èª°ãããªãæ¡ä»¶ã§ããããã1åéãã€ç«ã®è¡åã芳å¯ããŸããããã®çµæãç«ã鳎ããåæ°ã¯äººããããšãã86åãã²ãšãã®ãšãã20åã§ã人ããããšé³Žã確çã¯16å以äžã«é«ãŸããŸãããç«ã¯é³Žããªããäººã®æ¹ãèŠããã人ãšããã€ã亀äºã«èŠããããããšãå€ããã²ãšãã®ãšãã¯ãã£ãšç«ã¡æ¢ãŸã£ãŠãã¢ã®æ¹ãèŠãŠéããæéãé·ãã£ããšãããŸãã
ãã®çµæã¯ãç«ã®ããã£ãŒããåãªãææ ã®è¡šãã§ã¯ãªãã人ã«åããã³ãã¥ãã±ãŒã·ã§ã³ã®ææ®µãšããŠäœ¿ãããŠããå¯èœæ§ã瀺ããŠããŸãããã ããç«ãã人ãªãåé¡ã解決ã§ããããšçè§£ããŠé³ŽããŠããã®ãã©ãããŸã§ã¯ããã®ç ç©¶ã§ã¯ç¢ºãããããŠããŸããããŸããé æ°ãå°ãªããããšããšé£ã¹ç©ã®åã§ãã鳎ãç«ã ãã察象ã«ããŠãããããããŸã鳎ããªãç«ã«ãåãããšãåœãŠã¯ãŸããšã¯éããŸãããç ç©¶ããŒã ã¯ä»åŸãç«ã欲ãããã®ã«ãã£ãŠé³Žãæ¹ã䜿ãåããŠãããã©ããã調ã¹ãããšããŠããŸããæç«ããã¡ããèŠãªãã鳎ããšãã¯äœããäŒããããšããŠãããµã€ã³ãããããŸãããã鳎ããã³ã«ããã€ãäžãããšèŠæ±é³Žãã匷ãŸãããšããããããé£äºã®æéãšéãæ±ºããŠå¯Ÿå¿ãããšããã§ããããæ¥ã«é³Žã声ãå¢ãããå€äžã«å€§å£°ã§é³Žãããã«ãªã£ããšãã£ãå€åã¯ãç²ç¶è ºã®ç æ°ãé«éœ¢ã«ããå€åãé ããŠããããšããããããç£å»åž«ã«çžè«ããŠãã ããã
ð https://theprint.in/science/cats-likely-meow-on-purpose-to-ask-humans-for-help-study-finds/3097096/
ð·ïž ãã¬ãŒãã³ã°ã»è¡åç§åŠ
ð¡ 仿¥ã®ã¯ã³ãã€ã³ã
ç«ã¯å ·åã®æªããé ãã®ãåŸæã§ã幎ãéããŠãèŠãç®ã¯å æ°ã«èŠããããšãå°ãªããããŸããã7æ³ãéããããäœéãèäžãŸããã®çèã®ä»ãå ·åãé³Žãæ¹ã鳎ãåæ°ãªã©ããµã ãã®æ§åãæã ãã§ãã¯ããŠã¿ãŸãããããæè¿ã¡ãã£ãšéãããšæãããããããåç©ç é¢ã«çžè«ããããã¿ã€ãã³ã°ã§ãã
æ¯æ7æé ä¿¡

ã³ã¡ã³ããã©ãã